Call for Papers and Author Guidelines
Pharmaceutical Discovery and Development is designed to unite the growing community of pharmaceutical and life science researchers involved in the emerging fields of genomic and proteomic drug discovery. Published in the same tradition that has made LCGC one of the most respected publications in the analytical chemistry field,
Pharmaceutical Discovery and Development covers the practical aspects of applied discovery-oriented pharmaceutical research. Our emphasis is on providing high-quality technical information that helps chemists and life scientists accelerate, automate, and enhance the effectiveness of their research.
Pharmaceutical Discovery and Development focuses on the laboratory technologies and information management tools that are enabling the current explosion of discovery in the post-genomic era.
Pharmaceutical Discovery and Development
reaches a global audience of 40,000 scientists and laboratory managers working in pharmaceutical companies, contract research organizations, government laboratories, academia, and related areas.
The editors of Pharmaceutical Discovery and Development
invite contributed manuscripts from scientists involved in the full range of pharmaceutical research and development, including analytical technologies for drug target identification, lead generation, and lead optimization, and welcomes manuscripts that describe techniques and applications of all forms of genomic technology and that are of immediate interest to users in industry, academia, and government. Send manuscripts to:
Please
send manuscripts for consideration to Laurie Sullivan
at:
Cambridge Healthtech Institute
250 First Avenue Suite 300 Needham
Massachusetts 02494
or e-mail them to lsullivan@pharmadd.com.
Manuscripts are reviewed with the understanding that they have not been published previously and are not under consideration for publication elsewhere. Authors are responsible for all statements made in their work. All manuscripts are subject to peer review and copyediting. Authors of accepted papers will have an opportunity to review galleys. Upon acceptance, copyright of the manuscript is transferred to
Pharmaceutical Discovery and Development. If illustrations or other material in a manuscript have been published previously, the author is responsible for obtaining permission to republish. Rejected manuscripts are returned on request.
Pharmaceutical Discovery and Development is not responsible for loss of materials.
EDITORIAL FOCUS
Because Pharmaceutical Discovery and Development is directed to experienced researchers and applications personnel in the field of drug discovery, avoid describing details or techniques that are common knowledge among such specialists.
Five types of articles are suitable for Pharmaceutical Discovery and Development:
• Feature articles survey current techniques or emerging technologies. Manuscripts should be 10-15 pages (2500-3750 words) long. We urge authors to submit a proposal to the editor before completing a manuscript.
• Technical articles describe improved methods or improvements in techniques. Papers should be 5-10 pages (1250-2500 words) long and should be of immediate relevance to pharmaceutical researchers. Manuscripts should be presented in an abbreviated scientific format and should include the following:
• Abstract:
Very brief. Mention subjects studied, methods used, principal observations made, and conclusions reached.
Introduction: Without repeating published information, discuss the relationship of your work to previously published work. Describe the novelty or importance of the research presented.
• Experimental:
Present enough information that an experienced researcher would be able to reproduce the work. List those components of the experimental design that are of a specialized nature, including equipment manufacturers' names and locations in parentheses after reference to specific types of equipment. Do not list equipment, reagents, or procedures that are normally found in the laboratory or that are common knowledge in the field.
• Results and discussion: Focus your comments on the needs of drug discovery researchers; stress the practical importance of your findings.
Conclusion: Summarize the main points of your article; state important conclusions or recommendations
Technical notes are brief descriptions of equipment modifications and designs that provide tips on improved efficiency in equipment use or advice on cutting costs. Manuscripts should be 1-4 pages (250-1000 words) long.
Back to Basics articles describe the historical background, current and potential applications, basic theory, instrumental setup, and advantages and limitations of a new or existing drug discovery-related technique. Manuscripts should be 3-6 pages (750-1500 words) long.
Application - Focus articles describe results obtained using a specific instrument or device. Manuscripts should be 2-5 pages (500-1250 words) long.
MANUSCRIPT PREPARATION
For papers with multiple authors, designate a single author to handle correspondence. Include this author's full mailing address, telephone number, fax number, and e-mail address in the cover letter that accompanies the manuscript. Before submitting the completed work, authors are urged to review manuscripts for clarity of expression, details of grammar, and typographical accuracy. Send one original and two copies.
Manuscripts must be typewritten (double-spaced) with liberal margins and space at the top and bottom of the page. We encourage authors to submit manuscripts on computer diskette; contact the editor for information. Begin each of the following on a separate page: title page (with each author's name, affiliation, and title), abstract, the first page of the text, references, captions for illustrations, and tables. Titles should be short, specific, and clear. Beginning with the first page of text, number each page consecutively.
ILLUSTRATIONS
If illustrations or other material in a manuscript have been published previously, the author is responsible for obtaining permission to republish. Refer to photographs, line drawings, and graphs in the text using arabic numerals in consecutive order (Figure 1, Figure 2, etc.). Omit all illustrations that do not enhance the reader's understanding of the text. Line drawings, graphs, and charts must be professionally rendered and submitted camera-ready as high-quality, glossy, photographic prints or clean ink drawings. Identify all illustrative material by the figure number and first author's name on the reverse side using a nonbleeding felt-tip pen. Provide figure captions on a separate page, each identified by its proper number and title.
TABLES
Each table should be typed (double-spaced) on a separate sheet of paper, with the first author's name on the reverse side. Refer to tables in the text by roman numerals in consecutive order (Table I, Table II, etc.). Every table and each column must have an appropriate heading. Table number and title must be placed in a continuous heading above the data presented. Omit tables that contain information already included in the text.
REFERENCES
Literature citations in the text must be indicated by arabic numerals in parentheses. Number each reference separately in the order in which it appears in the text. List cited references at the end of the manuscript in the order of their appearance in the text - not alphabetically. Designate submitted articles as "in press" only if they are formally accepted for publication and give the future volume number and year, if possible. Use "unpublished work" otherwise, giving the date when the work was completed. For personal communications, include name and date.
Use the following format for references:
1. T.L. Einmann and C. Champaign, Science 387, 922-930 (1981).
2. E. Mitosouki and F.G. Pleinum, in Natural Cell-Mediated Immunity Against Infection, W.J. Kinman, Ed. (Plenum Press, New York, 1980), pp. 345-376.
|
